Family Medicine · Van Nuys, CA
NPI
1467530121
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
13321 Victory Blvd
Van Nuys, CA, 91401
Phone (818) 780-0101
Groups this clinician bills Medicare through
Medicare paid, 2024
$777K
11,324 services
Medicare patients, 2024
963
Average age 72
Drug cost, 2024
$10.8M
99,093 prescriptions
Company payments, 2025
$3,724
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vagharshak M Pilossyan was code 99213 (office e&m - established), 7,600 times for 918 patients. In total Vagharshak M Pilossyan billed 11,324 services in 21 codes, and Medicare paid $777K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-06-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 7,600 | 918 | $71.87 | $546K |
| 99214 Office E&M - Established | Office | 963 | 444 | $97.48 | $94K |
| 36415 Venipuncture Blood Collection | Office | 900 | 568 | $8.65 | $7,785 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 466 | 466 | $139.85 | $65K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 434 | 434 | $21.03 | $9,128 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 345 | 195 | $35.56 | $12K |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 263 | 197 | $45.84 | $12K |
| 93000 Electrocardiogram | Office | 134 | 122 | $10.94 | $1,466 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 70 | 70 | $176.60 | $12K |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 37 | 37 | $177.40 | $6,564 |
| 99204 Office E&M - New | Office | 35 | 35 | $92.75 | $3,246 |
| 99442 Telephone Services | Office | 20 | 14 | $68.00 | $1,360 |
| 99497 Care Management/Coordination | Office | 11 | 11 | $40.17 | $442 |
By year: 2022 $816K for 11,894 services; 2023 $801K for 11,721 services; 2024 $777K for 11,324 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 900 | 568 | $8.65 | $7,785 |
Medicare prescription drug claims, 2024
In 2024, the drug Vagharshak M Pilossyan prescribed most often to Medicare patients was Atorvastatin Calcium, with 3,765 prescriptions and refills. In total Vagharshak M Pilossyan wrote 99,093 Medicare prescriptions that cost $10.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 3,765 | 4,029 | 436 | $9,069 |
| Gabapentin Generic | 3,025 | 3,088 | 345 | $10K |
| Omeprazole Generic | 2,778 | 2,901 | 361 | $6,568 |
| Amlodipine Besylate Generic | 2,534 | 2,733 | 297 | $2,567 |
| Ezetimibe Generic | 2,320 | 2,452 | 261 | $12K |
| Rosuvastatin Calcium Generic | 1,874 | 2,032 | 219 | $6,887 |
| Metformin Hcl Generic | 1,850 | 1,959 | 220 | $171K |
| Vascepa Icosapent Ethyl | 1,834 | 1,906 | 251 | $603K |
| Tamsulosin Hcl Generic | 1,757 | 1,866 | 199 | $6,113 |
| Carvedilol Generic | 1,703 | 1,783 | 196 | $3,690 |
| Clonidine Hcl Generic | 1,669 | 1,695 | 180 | $2,973 |
| Meclizine Hcl Generic | 1,668 | 1,692 | 218 | $6,080 |
| Metoprolol Tartrate Generic | 1,623 | 1,721 | 190 | $2,427 |
| Ibuprofen Generic | 1,531 | 1,541 | 222 | $6,144 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 1,461 | 1,561 | 169 | $5,618 |
Brand drugs: 16,577 claims; generic drugs: 80,644 claims; opioid claims: 1,278.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vagharshak M Pilossyan $3,724 ($3,724 in general payments such as food, travel and fees) from 29 companies. The largest payer was Amgen Inc. with $613.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 5 | $613 |
| Abbvie Inc. ABBV | 18 | $535 |
| Novartis Pharmaceuticals Corporation NVS | 17 | $410 |
| Ardelyx, Inc. ARDX | 11 | $279 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $269 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 10 | $177 |
| Edwards Lifesciences Corporation EW | 1 | $157 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $143 |
| Esperion Therapeutics, Inc. ESPR | 5 | $119 |
| Aimmune Therapeutics, Inc. | 4 | $111 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.